Mergers & Acquisitions -

Filter

Current filters:

Popular Filters

28 to 52 of 840 results

Galapagos sells service operations to Charles River for up to 34 million euros

Galapagos sells service operations to Charles River for up to 34 million euros

14-03-2014

Belgian biotech firm Galapagos has signed a definitive agreement to sell the BioFocus and Argenta service…

ArgentaBiotechnologyCharles River LaboratoriesGalapagosMergers & Acquisitions

Vectura to buy Germany’s Activaero for 130 million euros

Vectura to buy Germany’s Activaero for 130 million euros

14-03-2014

UK developer of inhaled therapies Vectura says it is acquiring privately-held German company Activaero…

ActivaeroFinancialMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

Islet Sciences to acquire BHV Pharma along with diabetes and NASH products

Islet Sciences to acquire BHV Pharma along with diabetes and NASH products

13-03-2014

US biotech firm Islet Sciences says it has signed a binding letter of intent to acquire Brighthaven Ventures…

BiotechnologyDiabetesIslet SciencesMergers & AcquisitionsNephrology and Hepatologyremogliflozin

UK cancer drug companies combine expertise in merger

UK cancer drug companies combine expertise in merger

13-03-2014

UK oncology company Incanthera says it has acquired Onco-NX, the University of Salford drug discovery…

IncantheraMergers & AcquisitionsOnco-NXOncologyPharmaceutical

Sustainability of sky-high M&A valuations will be the biggest question for 2014, says new report

12-03-2014

The cautious optimism of 2012 turned into a fully fledged biotech boom in 2013, marked by surging company…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

12-03-2014

When Merck & Co acquired Schering-Plough in 2009, the corporate real estate team reduced the combined…

ManagementMerck & CoMergers & AcquisitionsPharmaceutical

GSK increases stake in Indian Pharma subsidiary to 75%

GSK increases stake in Indian Pharma subsidiary to 75%

10-03-2014

UK pharma giant GlaxoSmithKline says that, following the voluntary open offer undertaken by its Indian…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

Debiopharm to acquire products or companies to expand activities at Swiss manufacturing facility

06-03-2014

Swiss independent drug developer Debiopharm say it plans to expand and optimize activities at Debiopharm…

DebiopharmMergers & AcquisitionsPharmaceuticalProduction

Oxford Gene Technology acquires Cytocell to expand genomics offering

Oxford Gene Technology acquires Cytocell to expand genomics offering

04-03-2014

Genetic research company Oxford Gene Technology has acquired Cambridge-based Cytocell, a leading provider…

BiotechnologyGeneticsMergers & AcquisitionsOxford Gene TechnologyUK

Ohr Pharma and Cold Spring Harbor Lab set up JV to develop trodusquemine

03-03-2014

US biotech firm Ohr Pharmaceutical and not-for-profit cancer research center Cold Spring Harbor Laboratory…

BiotechnologyDepYmedMergers & AcquisitionsOhr PharmaceuticalResearchtrodusquemine

Perrigo transfers ELND005 assets; buys OTC products

01-03-2014

Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

Israel's Clal Biotech in talks to sell Andromeda unit

28-02-2014

In an announcement to the Stock Exchange, Israeli firm Clal Biotechnology Industries said that, on February…

Andromeda BiotechBiotechnologyClal BiotechnologyDiabetesDiaPep277Mergers & AcquisitionsTeva Pharmaceutical Industries

Bayer to buy Chinese OTC/TCM drugmaker Dihon Pharma

27-02-2014

Germany’s leading pharma firm Bayer says it plans to acquire 100% of Dihon Pharmaceutical, a privately…

BayerDihon PharmaceuticalMergers & AcquisitionsPharmaceutical

Verastem acquires cancer stem cell inhibitor VS-4718 rights from Poniard

27-02-2014

US drug developer Verastem has acquired the license to VS-4718, which targets cancer stem cells, held…

BiotechnologyMergers & AcquisitionsOncologyPoniard PharmaceuticalsVerastemVS-4718

Way clear for Bayer to complete Algeta acquisition

26-02-2014

The way is now clear for Germany’s Bayer to acquire Norwegian pharmaceutical company Algeta, under…

AlgetaBayerMergers & AcquisitionsOncologyPharmaceuticalXofigo

ThromboGenics explores “strategic options” for the company

ThromboGenics explores “strategic options” for the company

24-02-2014

Belgian biotech firm ThromboGenics revealed this morning that it has retained financial advisor Morgan…

AlconBiotechnologyLicensingMergers & AcquisitionsNovartisOphthalmicsThromboGenics

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

Nestle takes full control of Galderma Pharma

19-02-2014

The boards of Switzerland-based Nestle, the world’s largest food company, and French cosmetics firm…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceutical

Actavis confirms plan to acquire Forest Labs for about $25 billion

Actavis confirms plan to acquire Forest Labs for about $25 billion

18-02-2014

After a morning of speculation and rumors, generics drug major Actavis today confirmed that it has reached…

ActavisForest LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

ProductLife Group expands German operations with acquisition

18-02-2014

UK life sciences outsourcing and consulting services specialist ProductLife Group (PLG) has announced…

Kohne PharmaMergers & AcquisitionsPharmaceuticalProductLife Group

Prothelia and Alexion partner with University of Nevada for ultra-rare neuromuscular disorder

Prothelia and Alexion partner with University of Nevada for ultra-rare neuromuscular disorder

17-02-2014

Privately-held USA-based Prothelia and the University of Nevada, Reno, have entered into strategic agreements…

Alexion PharmaceuticalsMergers & AcquisitionsPharmaceuticalProtheliaRare diseasesResearch

28 to 52 of 840 results

Back to top